The pathological features of ovarian neoplasia

Cancer of the Ovary

Volumn , Issue , 2006, Pages 20-46

  Lowe, David ^a  

^a London Clinic Cancer Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954837673     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545887.004     Document Type: Chapter

References (60)

1. R. T. Greenlee, M. B. Hill-Harmon, T. Murray, et al. Cancer statistics. CA Cancer J Clin(2001), 51:15–36.
2. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, et al. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med(2003), 348:1625–38.
3. D. E. Marsden, M. Friedlander and N. F. Hacker. Current management of epithelial ovarian carcinoma: a review. Semin Surg Oncol(2000), 19:11–19.
4. I. J. Jacobs, S. J. Skates, N. MacDonald, et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet(1999), 353:1207–10.
5. B. Pothuri, M. Leitao, R. Baracat, et al. Genetic analysis of ovarian carcinoma histogenesis. Gynecol Oncol(2001), 80:277.
6. W. H. Wen, A. Reles, I. B. Runnebaum, et al. p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol(1999), 18:29–41.
7. J. M. Schildkraut, E. Bastos and A. Berchuck. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst(1997), 89:932–8.
8. D. McClamrock and E. Y. Adashi. Polycystic ovarian syndrome and associated hirsutism in the adolescent. Adol Ped Gynecol(1992), 5:231–41.
9. Ovarian Tumour Panel of the Royal College of Obstetricians and Gynaecologists. Ovarian epithelial tumours of borderline malignancy: pathological features and current status. Br J Obstet Gynaecol(1983), 90:743–50.
10. H. Fox. Ovarian tumours of borderline malignancy: time for a reappraisal? Curr Diagnost Pathol(1996), 3:143–51.
11. D. A. Bell and R. E. Scully. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol(1990), 21:397–403.
12. A. I. Karseladze. On the site of origin of epithelial tumors of the ovary. J Gynaecol Oncol(2001), 22:110–15.
13. J. L. Rutgers and R. E. Scully. Ovarian mullerian mucinous papillary cystadenocarcinomas of borderline malignancy. A clinicopathologic analysis. Cancer(1988), 61:340–8.
14. S. A. Cannistra. Cancer of the ovary. N Engl J Med(1993), 329:1550–8.
15. J. M. Schildkraut and W. D. Thompson. Familial ovarian cancer: a population based casecontrol study. Am J Epidemiol(1988), 128:456–66.
16. R. P. Zweemer. Overview of the aetiology of familial ovarian cancer. In I. J. Jacobs, J. H. Shepherd, D. H. Oram, A. D. Blackett, D. M. Luesley, A. Berchuck, C. N. Hudson, eds., Ovarian Cancer(Oxford: Oxford University Press, 2002), pp. 29–35.
17. M. Boyd, F. Harris, R. McFarlane, et al. A human, BRCA1 gene knockout. Nature(1995), 375:541–2.
18. K. W. Kinzler and B. Vogelstein. Gatekeepers and caretakers. Nature(1997), 386:761–3.
19. A. Berchuck, M. F. Kohler, J. R. Marks, et al. The p53 tumor suppressor gene frequently is altered in gynecological cancers. Am J Obstet Gynecol(1994), 170:246–52.
20. S. M. Ginolhac, S. Gad, M. Corbex, et al. BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations. Cancer Epidemiol Biomarkers Prev(2003), 12:90–5.
21. C. B. Gilks, D. A. Bell and R. E. Scully. Serous psammocarcinoma of the ovary and peritoneum. Int J Gynecol Pathol(1990), 9:110–21.
22. K. R. Lee and R. E. Scully. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with pseudomyxoma peritonei. Am J Surg Pathol(2000), 24:1447–64.
23. H. D. Hoerl and W. R. Hart. Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow up. Am J Surg Pathol(1998), 22:1449–62.
24. S. Siraaunkgul, K. M. Robbins, L. McGowan, et al. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and mullerian type. Int J Gynecol Pathol(1995), 14:198–208.
25. B. M. Ronnet, R. J. Kurman, B. M. Schmookler, et al. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol(1997), 21:1144–56.
26. Y. Katsube, J. W. Berg and S. G. Silverberg. Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area 1 July–31 December 1969 and 1 July–31 December 1979. Int J Gynecol Pathol(1982), 1:3–16.
27. R. E. Scully, D. A. Bell and G. M. Abu-Jawdeh, Update on early ovarian cancer developing in benign ovarian tumors. In P. Mason, P. Sharp, T. Blackett, J. Berek, eds., Ovarian Cancer3(London: Chapman, Hall, 1995), pp. 139–44.
28. M. Brincat, R. Galea and A. Buhagiar. Polycystic ovaries and endometriosis: a possible connection. Br J Obstet Gynaecol(1994), 101:346–8.
29. T. A. Mahmood and A. Templeton. Prevalence and genesis of endometriosis. Hum Reprod(1991), 6:544–9.
30. R. C. Kline, J. T. Wharton, E. N. Atkinson, et al. Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol(1980), 39:337–46.
31. S. S. Falkenberry, M. M. Stainhoff, M. Gordinier, et al. Synchronous endometrioid tumors of the ovary and endometrium. A clinicopathologic study of 22 cases. J Reprod Med(1996), 41:713–18.
32. V. T. Smit, C. J. Cornelisse, D. De Jong, et al. Analysis of tumor heterogeneity in a patient with synchronously occurring female genital tract malignancies by DNA flow cytometry, DNA fingerprinting and immunohistochemistry. Cancer(1988), 62:1146–52.
33. S. B. Lele, M. S. Piver, J. J. Barlow, et al. Squamous cell carcinoma arising in ovarian endometriosis. Gynecol Oncol(1978), 6:290–3.
34. R. H. Young, J. Prat and R. E. Scully. Ovarian endometrioid carcinomas resembling sex cord stromal tumours. A clinicopathological analysis of 13 cases. Am J Surg Pathol(1982), 6:513–22.
35. R. E. Scully, R. H. Young and P. B. Clement, eds. Atlas of Tumor Pathology: Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tubes, and Broad Ligament, 3rd edn., (Washington, DC: Armed Forces Institute of Pathology, 1998).
36. C. Tomos, E. G. Silva, S. M. Khorana, et al. High stage endometrioid carcinoma of the ovary. Prognostic significance of pure versus mixed histologic types. Am J Surg Path(1994), 18:687–93.
37. W. Pokieser, R. Schmerker, M. Kisser, et al. Clear cell carcinoma arising in endometriosis of the rectum following progestin therapy. Path Res Pract(2002), 198:121–4.
38. F. D. Cirisano Jr, S. J. Robboy, R. K. Dodge, et al. The outcome of stage I–II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol(2000), 77:55–65.
39. N. G. Ordonez. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different. Histopathology(2000), 36:433–8.
40. I. Reidel, B. Czernobilsky, B. Lifschitz-Mercer, et al. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchows Arch(2001), 438:181–91.
41. M. J. Costa, C. Hansen, A. Dickerman, et al. Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalised ovarian epithelial tumors (stages 2–4). Am J Clin Pathol(1998), 109:173–80.
42. A. O. Vortmejey, M. Devouassoux-Shisheboran, G. Li, et al. Microdissection based analysis of mature ovarian teratoma. Am J Pathol(1999), 154:987–91.
43. G. M. Kleiman, R. H. Young and R. E. Scully. Primary neuroectodermal tumors of the ovary. A report of 25 cases. Am J Surg Pathol(1993), 17:764–78.
44. C. J. Zaloudek, F. A. Tavassoli and H. J. Norris. Dysgerminoma with syncytiotrophoblastic giant cells. A histologically and clinically distinctive subtype of dysgerminoma. Am J Surg Pathol(1981), 5:361–7.
45. B. Lifschitz-Mercer, H. Walt, I. Kushnir, et al. Differentiation potential of ovarian dysgerminoma: an immunohistochemical study of 15 cases. Hum Pathol(1995), 26:62–6.
46. G. A. Niehans, J. C. Manivel, G. T. Copland, et al. Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer(1988), 62:1113–23.
47. F. F. Nogales. Embryonic clues to human yolk sac tumors: a review. Int J Gynecol Pathol(1993), 12:101–7.
48. B. F. King and A. C. Enders, The Human Yolk Sac and Yolk Sac Tumours. Berlin: Springer, 1993.
49. D. C. Gee and P. Russell. The pathological assessment of ovarian neoplasms. IV. The sex cord stromal tumours. Pathology(1981), 13:235–55.
50. N. Singh, and D. G. Lowe. Primary non-epithelial ovarian cancers. In I. J. Jacobs, J. H. Shepherd, D. H. Oram, A. D. Blackett, D. M. Luesley, A. Berchuck, C. N. Hudson, eds., Ovarian Cancer(Oxford: Oxford University Press 2002), pp. 75–84.
51. P. B. Clement, R. H. Young, W. Hanna, et al. Sclerosing peritonitis associated with luteinised thecomas of the ovary. A clinicopathologic study of six cases. Am J Surg Pathol(1994), 18:1–13.
52. J. V. Meigs. Fibroma of the ovary with ascites and hydrothorax. Meigs’ syndrome. Am J Obstet Gynecol(1954), 67:962–87.
53. R. A. Dumont-Herslowitz, H. S. Safaii and B. Senior. Ovarian fibromata in four successive generations. J Pedriatr(1978), 93:621–4.
54. J. Prat and R. E. Scully. Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases. Cancer(1981), 47:2663–70.
55. J. Prat, R. H. Young and R. E. Scully. Ovarian Sertoli-Leydig cell tumors with heterologous elements. II Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases. Cancer(1982), 50:2465–75.
56. W. Zheng, C. J. Sung, I. Hanna, et al. a and b subunits of inhibin/activin as sex cord stromal differentiation markers. Int J Gynecol Pathol(1997), 16:263–71.
57. P. Kruckenberg. Ueben das Fibrosarcoma ovarii mucocellulari (carcinomatase). Archiv Gynecol(1896), 50:287–321.
58. N. Singh, and D. G. Lowe. Metastases in the ovary. In I. J. Jacobs, J. H. Shepherd, D. H. Oram, A. D. Blackett, D. M. Luesley, A. Berchuck, C. N. Hudson, eds., Ovarian Cancer(Oxford: Oxford University Press 2002), 785–9.
59. J. C. Lathrop. Malignant pelvic lymphomas. Obstet Gynaecol(1967), 30:137–45.
60. R. E. Scully. World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer Inst Monogr(1975), 42:5–7.